5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Phase (Preclinical Studies, Phase I, Phase II, Phase III and Phase IV), Service Type and Geography
Fastest Growing Market:
The clinical trials support services market will show a rapid growth due to the demand for clinical trials in the emerging markets, high R&D spending of the pharmaceutical industry and the increasing number of CROs and prevalence of diseases.
In the emerging countries, there are numerous unmet needs of clinical trials for novel drugs, due to the increasing prevalence of infectious and tropical diseases in the region. The number of individuals suffering from insulin resistance, hyperlipidemia, and obesity is increasing rapidly in these regions and , the cost of conducting clinical trials is relatively cheaper, due to less labor costs and low costs for handling clinical trial supplies. Thus the demand for clinical trials in emerging countries is expected to drive the clinical trials support services market’s growth over the forecast period.
The research and development (R&D) spending of pharmaceutical companies has also been steadily increasing over the past few years. This was mainly due to numerous patent expiries, and as a result of the patent expiration, there are many pharmaceutical companies that will have no other option but to develop new revolutionary molecules for survival. Therefore, the companies are spending more on R&D to accelerate the development of drugs through clinical trials, and henceforth increasing the overall market.
As per the scope of the report, clinical trial support services are the various services, which pharmaceutical companies use during the clinical trials they conduct, either for the approval of new drug molecules or for the introduction of generics and biosimilars into the market.
|By Service Type|
|Clinical Trial Site Management|
|Patient Recruitment Management|
|Packaging, Storage and Distribution Services|
|Other Service Types|
Report scope can be customized per your requirements. Click here.
Clinical trials support services for phase-I include services, like early-phase patient screening, sample collection management, data management, and assay redesign services, among others. The United States, Europe, and China, followed by Canada and Australia are thus found be the major hubs, where a large set of Phase-I clinical trials are being registered and conducted. Thus, it is a major market for clinical trial management services.
Despite the trend of outsourcing, the developing countries host a significantly small fraction of Phase I trials. Thus the increasing number of Investigative New Drug (IND) applications filed and the trend of outsourcing plays a major role in the drug development process.
To understand key trends, Download Sample Report
North America is found to be one of the largest market for global clinical trials support services owing to the maximum number of pharmaceutical firms based in the United States to conduct most of their business in this region. There are also increasing R&D investments and growing demand for drug development that are the main factors for the growth of the overall market.
Moreover, owing to the trend of clinical trial outsourcing, the clinical trial site management services, for managing offshore operations has witnessed rapid growth.
To understand geography trends, Download Sample Report.
Product launches, partnerships, collaborations, agreements, and market expansions were the key strategies adopted by players to grow and expand their presence in the clinical trial management system market. The major players include Accovion GmbH, Alcura Health, Charles River Laboratories, Chiltern International Limited, Covance, Inc., ICON PLC, Parexel International, Pharmaceutical Product Development LLC, Pharmnet, Quotient Bioresearch, and WuXi PharmaTech, among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Demand for Clinical Trials in the Emerging Markets
4.2.2 High R&D Spending of the Pharmaceutical Industry
4.2.3 Increasing Number of CROs and Prevalence of Diseases
4.3 Market Restraints
4.3.1 Lack of Adequate Regulatory Framework for Conducting Clinical Trials in some Countries
4.3.2 Stringent Regulations for Patient Enrollment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Phase
5.1.1 Preclinical Studies
5.1.2 Phase I
5.1.3 Phase II
5.1.4 Phase III
5.1.5 Phase IV
5.2 By Service Type
5.2.1 Clinical Trial Site Management
5.2.2 Patient Recruitment Management
5.2.3 Assay Development
5.2.4 Clinical Research
5.2.5 Contract Manufacturing
5.2.6 Packaging, Storage and Distribution Services
5.2.8 Other Service Types
5.3.1 North America
184.108.40.206 Rest of Europe
5.3.3 Asia Pacific
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.3.4 Middle East and Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East and Africa
5.3.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Charles River Laboratories Intl Inc.
6.1.2 Eurofins Scientific SE
6.1.3 Laboratory Corp. of America Holdings
6.1.4 The Pharmaceutical Product Development LLC
6.1.6 Insight Genetics
6.1.7 Parexel International
6.1.8 Icon PLC
6.1.10 WuXi AppTec
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments